Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders

被引:7
|
作者
Fischer, Kai F. [1 ]
Simon, Maria S. [1 ]
Elsner, Julie [3 ]
Dobmeier, Johanna [4 ]
Dorr, Johannes [5 ]
Blei, Leonie [1 ]
Zill, Peter [1 ]
Obermeier, Michael [2 ]
Musil, Richard [1 ]
机构
[1] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Univ Hosp, Nussbaumstr 7, D-80336 Munich, Germany
[2] GKM Gesell Therapieforsch mbH, Munich, Germany
[3] Univ British Columbia, Inst Mental Hlth UBC, Vancouver, BC, Canada
[4] Endopraxis Amberg, Amberg, Germany
[5] Clin Internal Med South, Munich, Germany
关键词
Childhood trauma; Inflammation; CRP; Depressive disorder; Treatment resistance; BECK DEPRESSION INVENTORY; BODY-MASS INDEX; INFLAMMATORY BIOMARKERS; EPIGENETIC REGULATION; BIPOLAR DISORDER; EXPERIENCES; ABUSE; MALTREATMENT; ADULTS; METAANALYSIS;
D O I
10.1007/s00406-021-01245-z
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Adverse Childhood Experiences (ACE) are a well-known risk-factor for depression. Additionally, (high-sensitive) C-reactive Protein (hsCRP) is elevated in subgroups of depressed patients and high following ACE. In this context the literature considers hsCRP and ACE to be associated with treatment resistant depression. With the data being heterogenous, this study aimed to explore the associations of ACE, hsCRP levels and response to antidepressant treatment in uni- and bipolar depression. N = 76 patients diagnosed with uni- or bipolar depression and N = 53 healthy controls were included. Treatment was over 6 weeks in an inpatient psychiatric setting within an observatory study design. Depressive symptoms were assessed by the Montgomery-Asberg Depression Rating Scale (MADRS), ACE were assessed by the Childhood Trauma Questionnaire (CTQ); the body-mass-index (BMI) and hsCRP were measured. HsCRP levels did not differ between the study population and the healthy controls. While the depressive symptoms decreased, the hsCRP levels increased. Sexual abuse was associated with significant higher and emotional abuse with lower levels of hsCRP after 6 weeks. The baseline hsCRP levels and the ACE subgroups did not show significant associations with the treatment response in unipolar depressed patients. The long-lasting effects of specific forms of ACE may have relevant impact on inflammation, supporting hsCRP to be a suitable biomarker. With ACE and hsCRP not showing any significant associations with treatment response in the unipolar depressed subgroup, a more differentiate research concerning biomarkers and treatment regimens is needed when talking about treatment response.
引用
收藏
页码:1331 / 1341
页数:11
相关论文
共 50 条
  • [31] Brain Hippocampal volume, Cortisol and C-Reactive Protein Levels Relationship With Antidepressant Response in Patients With Major Depressive Disorder
    Zarate, Patricio
    Ontiveros, Alfonso
    Velez, Jorge
    Vales, Lucia
    Ortega, Jessica
    BIOLOGICAL PSYCHIATRY, 2022, 91 (09) : S230 - S231
  • [32] Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements
    Wilson, Douglas
    Moosa, Mahomed-Yunus S.
    Cohen, Ted
    Cudahy, Patrick
    Aldous, Collen
    Maartens, Gary
    OPEN FORUM INFECTIOUS DISEASES, 2018, 5 (11):
  • [33] Baseline C-Reactive Protein As A Predictor Of Response To Treatment In Depression.
    Zahoor, Bushra
    Kumar, Manoj
    INDIAN JOURNAL OF PSYCHIATRY, 2023, 65 : S85 - S85
  • [34] Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancer
    Badakhshi, Harun
    Kaul, David
    Zhao, Kuai-Le
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 643 - 647
  • [35] Effect of the inflammatory biomarker C-reactive protein on response to lurasidone treatment in patients with bipolar depression
    Pikalov, A.
    Raison, C.
    Siu, C.
    Tsai, J.
    Koblan, K.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S839 - S839
  • [36] Baseline serum C-reactive protein levels may predict antidepressant treatment responses in patients with major depressive disorder
    Zhang Jun
    Yue Yingying
    Ashok, Thapa
    Fang Jianzhong
    Zhao Shengjun
    Shi Weihua
    Yang Zhong
    Li Yanfang
    Yuan Yonggui
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 250 : 432 - 438
  • [37] C-REACTIVE PROTEIN PREDICTS RESPONSE TO INFLIXIMAB IN PATIENTS WITH CHRONIC SARCOIDOSIS
    Sweiss, N. J.
    Barnathan, E. S.
    Lo, K.
    Judson, M. A.
    Baughman, R.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2010, 27 (01) : 49 - 56
  • [38] Psychiatric disorders, body mass index and C-reactive protein in dialysis patients
    Preljevic, Valjbona Tiric
    Osthus, Tone Brit Hortemo
    Sandvik, Leiv
    Bringager, Christine Bull
    Opjordsmoen, Stein
    Nordhus, Inger Hilde
    Os, Ingrid
    Dammen, Toril
    GENERAL HOSPITAL PSYCHIATRY, 2011, 33 (05) : 454 - 461
  • [39] THE ROLE OF CHILDHOOD TRAUMA ON BODY MASS INDEX AND C-REACTIVE PROTEIN IN FIRST-EPISODE PSYCHOSIS
    Hepgul, N.
    Belvederi-Murri, M.
    DiForti, M.
    Dipasquale, S.
    Dazzan, P.
    Murray, R. M.
    Pariante, C. M.
    Mondelli, M.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2011, 25 (08) : A63 - A63
  • [40] Interleukin-2 and C-reactive protein in assessing the effectiveness of pulmonary sarcoidosis treatment
    Ostrovskyy, Mykola
    Shvets, Kostiantyn
    Ostrovska, Kseniia
    Savelikhina, Iryna
    Kulynych-Miskiv, Mariana
    Varunkiv, Oleksandr
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50